Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Albert

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Pageof 4